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Abstract 
Flurbiprofen is a kind of non-steroidal anti-inflammatory 
drug which has been widely used in clinic for treatment of 
rheumatoid arthritis and osteoarthritis. It has been 
reported that S-flurbiprofen shows good performance on 
clinic anti-inflammatory treatment, while R-enantiomer 
almost has no pharmacological activities. It has important 
practical values to obtain optically pure S-flurbiprofen. In 
this work, chiral ionic liquids which have good structural 
designability and chiral recognize ability were selected as 
the extraction selector by the assistance of quantum 
chemistry calculations. The distribution behaviors of 
flurbiprofen enantiomers were investigated in the 
extraction system, which composed of organic solvent 
and aqueous phase containing chiral ionic liquid. The 
results show that maximum enantioselectivity up to 1.20 
was attained at pH 2.0, 25 ഒ using 1,2-dichloroethane 
as organic solvent, 1-butyl-3-methylimidazole L-
tryptophan ([Bmim][L-trp]) as chiral selector. The racemic 
flurbiprofen initial concentration was 0.2 mmol:L-1 and 
[Bmim][L-trp] concentration was 0.02 mol:L-1. 
Furthermore, the recycle of chiral ionic liquids has been 
achieved by reverse extraction process of the aqueous 
phase with chiral selector, which is significant for 
industrial application of chiral ionic liquids and scale-up of 
the extraction process.
 




Flurbiprofen, namely (±)-2-(2-fluoro-4-biphenyl)-propionic acid, is 
a commonly used non-steroidal anti-inflammatory drug in clinic. It 
is one of the most effective drugs in this kind, better than aspirin 
and ibuprofen in anti-inflammatory and analgesic effects. It is 
mainly used for the treatment of rheumatoid arthritis, osteoarthritis 
and other diseases as a chiral compound (Figure 1).1,2 Its S 
enantiomer has less side effects, smaller dosage requirement and 
higher pharmacological activity compared with its racemate, while 
its R enantiomer has little therapeutic effect and presents some 
toxic side effects to the human body.3,4 In recent research, it has 
been found that the R enantiomer has a certain therapeutic effect 
on Helmer's disease, inhibiting tumor growth and reduction of 
neuropathic pain.5-11 However, at present, flurbiprofen is mainly 
produced and used as racemate. So it is significant to obtain pure 
enantiomers of flurbiprofen. 
.
 
FIGURE 1 The chemical structures of flurbiprofen enantiomers. (a) S-
flurbiprofen, (b) R-flurbiprofen. 
 
Now, the artificial monomeric enantiomers of chiral drug are 
mainly obtained through asymmetric chemical synthesis and 
racemic mixture resolution. Asymmetric chemical synthesis 
usually requires more complex synthetic process and higher cost, 
which is not conducive to industrial production.12-14 Nevertheless, 
the resolution of the racemate is relatively simple and it is possible 
to obtain two enantiomers simultaneously, which need to be 
considered.15,16 Most of the resolution methods, such as 
crystallization,17-19 kinetic resolution method,20-22 chromatographic 
resolution method,23 membrane separation method,24 etc., are 
difficult to achieve industrialization due to low capacity and narrow 
application range. Chromatography and electrochemical methods 
are mainly used for the analysis of enantiomers, currently.25-27 
However, chiral liquid-liquid extraction which applies the liquid-
liquid extraction technology to racemate separation is the most 
prospective method to scale-up because of low energy 
consumption, simple equipment requirements and mild operating 
conditions.16,28-33 Tang et al.34 reported enantioselective 
partitioning of flurbiprofen enantiomers in a biphasic recognition 
chiral extraction (BRCE) system combining a hydrophobic L-
tartrate in organic phase and hydrophilic-cyclodextrin derivative in 
aqueous phase, which preferentially recognize R-enantiomer and 
S-enantiomer, respectively. In these biphasic resolutions, the 
influence of the concentrations of the extractants and flurbiprofen 
enantiomers, the types of organic solvents and extractants, pH 
and temperature on the biphasic recognition process have been 
investigated and the enantioselectivity is 1.24 in optimized 
condition at 25 ഒ. Chen et al.35 also developed a method using 
aqueous two-phase extraction (ATPE) coupled with biphasic 
recognition chiral extraction to separate flurbiprofen by L-dioctyl 
tartrate and L-tryptophan and achieved good separation effect. 
But because of the more complex separation system, longer 
phase separation time and the use of a certain amount of salts 
(NH4SO4) as addictive, the extraction process is not beneficial to 
subsequent drug separation and the recycled utilization of 
extractants, which should be mainly considered and improved. 
In general, the selection of high enantioselectivity chiral selector 
is the key step of the flurbiprofen enantiomer resolution 
technology by liquid-liquid extraction.36 Ionic liquids which are 
composed of organic cations and inorganic or organic anions, 
have been extensively applied to electrochemical, chemical 
catalysis, gas absorption, extraction separation and other aspects 
recently, based on their negligible vapor pressure, good thermal 
stability, and adjustable structure.37-39 Chiral ionic liquid (CIL) 
which has chiral center in the molecular structure, with the general 
characteristics of chiral molecules, is an important subclass of 
ionic liquids with good chiral recognition ability. Recently, the 
related studies about chiral ionic liquids applied in 
chemical separation process have sustained grown, especially in 
enantioseparation extraction aspect.30,40-44 So, it is expected that 
the introduction of the chiral ionic liquid as a chiral selector into 
the enantioselective liquid-liquid extraction system of flurbiprofen 
can achieve a better separation effect. 
Quantum chemistry calculations has been proved to be a useful 
tool to investigate the structure-effective relationship, analyze the 
interaction relation and further predict the distribution behaviors of 
ionic liquids in the extraction separation process. Recently, we 
have successfully applied the quantum chemistry calculations for 
the guidance of chiral ionic liquids selection in the racemic 
amlodipine extraction system. The extraction system was 
consistent with the simulation calculation predictions and obtained 
favorable separation effect.30 Based on this work, the preliminary 
prediction before the extraction experiment for the optical isomer 
separation systems by the quantum chemistry calculations is 
feasible and simple, which should be considered for the 
flurbiprofen extraction process. 
In this work, the distribution behavior of flurbiprofen enantiomers 
is investigated in the chiral liquid-liquid extraction system, which 
is composed of organic solvent and the methanol aqueous 
solution containing chiral ionic liquid as an aqueous chiral 
extractant. The influence of chiral ionic liquid type was first studied 
with quantum chemistry calculation method by Gauss 16 
(Gaussian) software and further verified by extraction experiments, 
subsequently. The influences of the organic solvent, the 
concentration of chiral extractant, the concentration of drug 
enantiomers, the pH of aqueous phase and the temperature on 
enantioseparation were also optimized. Moreover, a reverse 
extraction process was also carried out to separate and recover 
the aqueous phase with chiral ionic liquid, which is conductive to 
industrial application of chiral ionic liquids.  
 
2. Materials and Methods 
 
2.1 Materials 
Flurbifropfen (racemate, purity > 99%) was purchased from J&K 
Chemical Co. Ltd. (Beijing, China). The standard reference 
sample of flurbifropfen (racemate, purity > 99.8%) was purchased 
from National Institutes for Food and Drug Control (Beijing, China). 
The R-flurbifropfen enantiomer standard sample (purity > 98%) 
was purchased from J&K Chemical Co. Ltd. (Beijing, China). 1-
Butyl-3-methylimidazolium L-tryptophan ([BMIM][L-trp], 97%), 1-
butyl-3-methylimidazolium L-phenylalanine ([BMIM][L-phe], 97%), 
1-butyl-3-methylimidazolium L-serinate ([BMIM][L-ser], 97%), 1-
butyl-3-methylimidazolium L-glutamate ([BMIM][L-glu], 97%) was 
purchased from Chengjie Chemical Co. Ltd (Shanghai, China). 
The molecular structures of the above chiral ionic liquids are 
displayed in Figure 2. 1,2-Dichloroethane (AR, 99%), 
dichloromethane (AR, 99.5%), methanol (HPLC grade, 99.5%) 
was purchased from Sinopharm Chemical Reagent Co. Ltd 
(China). n-Octanol (AR, 99%), n-decanol (AR, 98%), ethanol 
(HPLC grade, 99.8%), phosphoric acid (H3PO4, AR, 85%), sodium 
dihydrogenphosphate (NaH2PO4, AR, 99%), disodium 
hydrogenphosphate (Na2HPO4, AR, 99%), trifluoroacetic acid 
(TFA, HPLC grade, 99.5%) was purchased from Aladdin Reagent 
Co. Ltd (Shanghai, China). N-hexane(HPLC grade, 95%) was 
purchased from Sigma-Aldrich Chemical Co. Ltd. 
H3PO4/NaH2PO4/Na2HPO4 buffer solutions in different pH ranges 
were prepared by mixing of sodium dihydrogenphosphate, 
disodium hydrogenphosphate and phosphoric acid solutions (both 
0.3 mol/L) in proper proportions, and the pH measurements were 
performed with a pHs-3C digital pH-meter (LeiCi, Shanghai, 
China). 
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FIGURE 2 The molecular structures of chiral ionic liquids used in this 
work. (a) [BMIM][L-trp], (b) [BMIM][L-phe], (c) [BMIM][L-glu], (d) 
[BMIM][L-ser] 
 
2.2 Extraction Experiments 
Extraction process 
Chiral amino ionic liquid and flurbiprofen racemate dissolved in a 
certain pH 0.3 mol/L phosphate salt buffer solution. Due to poor 
solubility of flurbiprofen in water, 10% (v/v) methanol was added 
to improve its solubility in aqueous phase and it has been reported 
that the addition of alcohol has no influence on ibuprofen 
drugs.45,46 The aqueous phase was mixed with an equal volume 
of pure organic solvent as the organic phase and shaken for two 
hours until the phase equilibrium in a water bath at a fixed 
temperature. After completing phase separation, a small amount 
of organic phase was taken to determine the concentration of 
flurbiprofen enantiomers by HPLC. The concentration of 
flurbiprofen in aqueous phase can then be calculated with mass 
subtraction method. 
Reverse extraction process 
The extracted aqueous phase is collected, mixed with an equal 
volume of dichloromethane, and shaken at 25 °C for 2 hours to 
perform the reverse extraction process until phase equilibrium. 
After setting for a while and phase separation, the reverse 
extracted aqueous phase is re-used for extraction step to achieve 
the recovery of the aqueous phase containing the ionic liquid 
without further separation and purification. The schematic 




FIGURE 3 Schematic representation of the experimental procedure. 
 
2.3 Analytical Method 
The concentration of flurbiprofen enantiomers in organic phase 
was performed by HPLC using a UV detector (Agilent 1260 Infinity 
II) at the UV wavelength of 254 nm at 20 °C. The column was 
CHIRALPAKR IG (5 たm, 4.6 × 250 mm2). The mobile phase was 
hexane (containing 0.1% trifluoroacetic acid): ethanol (95:5, v/v) 
at a flow of 1mL:min-1. The inject volume is 20 たL. The retention 
time of the R-enantiomer is less than that of the S-enantiomer 
which was verified by the standard R-flurbiprofen enantiomers 
and the peaks of R-flurbiprofen and S-flurbiprofen enantiomer 
were completely separated. The standard curves of both R-
flurbiprofen (A = 119.05C+138.68, r = 0.9996, where A (mAu:s) is 
the peak area and C (たg:mL-1) is the enantiomer concentration) 
and S-flurbiprofen (A = 156.26C-31.41, r = 0.9992) were used to 
quantify the enantiomers. The detector responses were linear 
from 10 たg:mL-1 to 200.00 たg:mL-1 and the detection limit was 
0.06 たg:mL-1 for R-flurbiprofen and 0.12 たg:mL-1 for S-flurbiprofen. 
All the extraction processes were repeated at least three times. 
The standard uncertainties of measurement are u(T) = 0.1 ഒ, 
u(pH) = 0.01. The relative standard uncertainty of enantiomers 
concentration measurement is u = 0.6%.The reproducibility of 
distribution coefficient was within 5% and the reproducibility of the 
calculated enantioselectivity is within ±2%.  
2.4 Mechanism 
 
FIGURE 4 The mechanism of flurbiprofen extraction system. HAR and 
HAS represent the R-flurbiprofen and S-flurbiprofen molecules, 
respectively. AR- and AS- represent the R-flurbiprofen and S-
flurbiprofen ionics, respectively. 
 
The aqueous equilibrium and reaction extraction mechanism is 
shown in Figure 4. The equilibrium mechanism of the extraction 
system includes the distribution behaviors of flurbiprofen 
enantiomer molecules between the two phases, the dissociation 
equilibrium of flurbiprofen in aqueous phase and the 
diastereomeric complex equilibrium between the chiral ionic 
liquids and flurbiprofen enantiomer molecules due to molecular 
interactions such as hydrogen bond interaction, Van de Waals and 
electrostatic. 
Distribution coefficient (k) and operational enantioselectivity (g) 
of enantiomers in the equilibrium state are two important 
parameters to describe the efficiency of the chiral extraction 
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where CS,O and CS,W represent the concentrations of S-
flurbiprofen in organic phase and aqueous phase, respectively; 
CR,O and CR,W represent the concentrations of R-flurbiprofen in 
organic phase and aqueous phase, respectively; kS and kR are the 
distribution coefficients of S-flurbiprofen and R-flurbiprofen; g is 
the operational enantioselectivity, while the intrinsic 
enantioselectivty (gint) is the ratio of the complexation constants, 
which is the upper limit of g. 
 
3. Result and Discussion 
 
3.1 Quantum chemistry calculation details 
Quantum chemistry calculations in this work were performed 
with Gaussian 16 software. The density functional theory (DFT) 
and hybrid Becke 3-LeeYang-Parr (B3LYP) exchange-correlation 
functional with 6–31++G(d,p) basis set were applied to explore the 
proper geometries without any symmetry constraints. All of the 
optimizations were performed in vacuo and all optimized initial 
geometries were locally optimum on the potential energy surface 
verified by vibrational frequency calculations. Similar simulation 
process can be found in our previous work.30 In brief, firstly, the 
molecular conformations of S-flurbiprofen, R-flurbiprofen, the 
anion and cation of chiral ionic liquids were optimized under 
B3LYP/6-31++G(d,p) level on the basis of the reported 
conformations47-49 and selected by their chemical molecular 
potential energy. Then, the optimization ion pair geometries of 
chiral ionic liquids were studied by placing the anion and cation in 
different relative adjacent positions to form different initial 
geometries, which referred to the electrostatic distribution of 
optimized individual molecular structure, and optimizing 
respectively. The geometry with the lowest potential energy was 
chosen as the optimum conformation. The complexes of chiral 
ionic liquids and flurbiprofen enantiomers were optimized through 
similar procedures of ion pairs to obtain the global optimum. 
[Bmim][L-trp] in this work was chosen as a representative for brief 
description. The optimized geometries of the diastereomeric 
complex formed by [Bmim][L-trp] and S-flurbiprofen or R-
flurbiprofen at B3LYP/6-31++G(d,p) level are shown in Figure 5. It 
can be observed that the binding geometries of the two complexes 
are both affected by C-H…O interactions, distances of which are 
between 1.5 Å and 3.0 Å, indicating that the chiral recognition 
ability between [Bmim][L-Trp] and flurbiprofen enantiomers are 
mainly caused by hydrogen-bonding interactions. Because the 
number of hydrogen bonds is three in R-flurbiprofen-[Bmim][L-trp] 
complexion and two in S-flurbiprofen-[Bmim][L-trp] complexion, 
the former complexion is more stable than the latter. 
Subsequently, the complexation energy between chiral ionic 
liquids and flurbiprofen enantiomers were calculated by Gaussian 
16 and corrected by basis set superposition errors (BSSE) and 
zero-point energies (ZPE). The complexation energies difference 
(฀E) of the two optimization geometry was also calculated. The 
analogous simulation and calculation processes of three other 
extraction systems containing different chiral ionic liquids were 
also investigated and the results are shown in Table 1, where ฀ER 
and ฀ES represent for the complexation energy of chiral ionic 
liquid with R-flurbiprofen and S-flurbiprofen, respectively. ฀E 
represents for the energy difference which was calculated by 
subtracting ฀ER from ฀ES. It can be seen from Table 1. that the 
complexation energy of R-flurbiprofen-[Bmim][L-trp] is larger than 
that of S-flurbiprofen-[Bmim][L-trp], revealing that there exists 
stronger interaction between R-flurbiprofen and [Bmim][L-trp]. The 
analogous tendentiousness can be also found in [BMIM][L-glu] 
and [BMIM][L-phe] extraction system, while [BMIM][L-ser] system 
exhibits a weak opposite disparity. ฀E presents the discrepancies 
of interaction energy between two diastereomers formed by 
flurbiprofen enantiomers and chiral ionic liquid. The larger 
absolute value of ฀E often corresponds to higher selectivity 
referring to our previous work. So we guess that the [Bmim][L-trp] 
with larger ฀E is the better extractant and focus on it to perform 
the extraction experiments. 
     
FIGURE 5 Optimazed geometries of S-flurbiprofen-[Bmim][L-trp] and R-flurbiprofen-[Bmim][L-trp] at B3LYP/6-31++G(d,p) level. 
 
TABLE 1 BSSE and ZPE corrected interaction energies calculated on 
B3LYP/6–31++G(d,p) level. 
chiral ionic liquid ᇞER  ᇞES  ᇞE  
(kcal·mol-1) (kcal·mol-1) (kcal·mol-1) 
[BMIM][L-trp] -23.82 -20.9 2.92 
[BMIM][L-glu] -26.23 -24.6 1.63 
[BMIM][L-ser] -30.08 -31.3 -1.22 
[BMIM][L-phe] -23.55 -20.84 2.71 
 
3.2 Screening of chiral ionic liquids 
The 1-butyl-3-methylimidazole was selected as the cation of 
chiral ionic liquids and the influence of anion was further studied 
by extraction experiments to verify the quantum chemistry 
calculation results. Four different kinds of chiral anions including 
tryptophan, glutamic, phenylalanine and serine determined in the 
simulation section were used and the results are shown in Table 
2. It can be observed that [BMIM][L-glu] existing systems have low 
enantioselectivety under 1.05 which can’t meet the practical 
application requirements. The lower enantioselectiveties of them 
correspond to the smaller value of ฀E in the quantum chemistry 
calculations, referring to previous work.30,50 When [BMIM][L-ser] 
was employed as the extractant, an opposite enantioselectivity 
was obtained, which validated that its ฀ER > ฀ES and ฀E < 0. 
Distribution coefficient of R-flurbiprofen is definitely lower than that 
of S-flurbiprofen in the extraction systems including [Bmim][L-trp] 
or [Bmim][L-phe] as chiral selector, indicating that the molecular 
interaction between [Bmim][L-Trp] and R-flurbiprofen is higher 
than that of S-flurbiprofen, which accords with the quantum 
chemistry calculation results. The two systems have higher 
enantioselectivity and well distribution coefficient, probably due to 
the similar aromatic ring structure in amino acid anion, 
corresponding to the high ฀E in simulation calculations. 
Meanwhile, the overall effect of [Bmim][L-trp] system is slightly 
better than that of [Bmim][L-phe]. Thus, [Bmim][L-Trp] was 
selected as the chiral selector for the extraction system of 
flurbiprofen. The relationship between the energies difference (฀E) 
of diastereomers pairs and enantioselectivity was displayed in 
Figure 6. A positive correlation between the differences of 
complexation energy and enantioselectivities can be found, 
similar with our previous studies,30 which reveals the guidance 
meaning of quantum chemistry calculations results for the chiral 
extraction process. 
 
TABLE 2 The influence of different CILs on distribution coefficient and 
enantioselectivitya 
chiral ionic liquids kR kS g 
[BMIM][L-trp] 20.69 25.11 1.213 
[BMIM][L-glu] 20.46 22.05 1.077 
[BMIM][L-ser] 18.80 18.52 0.985 
[BMIM][L-phe] 20.23 23.85 1.180 
a. the concentration of CILs is 0.02 mol:L-1, the concentration of 
flurbiprofen is 0.2 mmol:L-1, the organic solvent is 1,2-dichloroethane, 
pH = 2.0, 25 ഒ. 
 
 
FIGURE 6 The relationship between enantioselectivity and ฀E 
calculated at B3LYP/6-31++G(d,p) level 
 
3.3 Influence of organic solvents 
Several solvents commonly used in chiral extraction process 
were employed in this work and the influence of different solvents 
on the distribution behavior of flurbiprofen enantiomers was 
determined with 0.02 mol:L-1 [Bmim][L-Trp] in aqueous phase at 
pH 2.0, 25 ഒ, as shown in Table 3. There is almost no 
enantioselectivity when n-hexane is used as solvent, and the 
distribution coefficient is relatively low. When dichloromethane is 
used as the organic solvent, the enantioselectivity of flurbiprofen 
enantiomers is 1.21, but the distribution coefficient reach up to 
around 40, which is too large to extract. However, 
dichloromethane may be used as the organic solvent in the 
reverse extraction step. The extraction selector [Bmim][L-Trp] can 
slightly dissolve in n-decanol and n-octanol, which causes the 
decrease of the distribution coefficients of the both enantiomers 
and an unsatisfactory selectivity. With comprehensive 
consideration of selectivity and distribution coefficient, 1,2-
dichloroethane is an appropriate organic solvent which shows 
high enantioselectivity and proper distribution coefficient, 
compared with all other hydrophobic organic solvents used in the 
experiment. 
 
TABLE 3 The influence of solvents on distribution coefficient and 
enantioselectivitya 
solvents kR kS g 
dichloroethane 20.03 24.09 1.203 
n-hexane 1.152 1.168 1.013 
n-decanol 15.48 16.89 1.091 
dichloromethane 36.06 42.11 1.167 
n-octanol 10.52 10.87 1.033 
a. the concentration of [Bmim][L-Trp] is 0.02 mol:L-1, the concentration 
of flurbiprofen is 0.2 mmol:L-1, pH = 2.0, 25 ഒ.  
 
3.4 Influence of pH 
pH is an important factor that affects the state of flurbiprofen 
molecules in the aqueous phase to further influence on the 
distribution behaviors in extraction system. The distribution 
coefficients and enantioselectivity of flurbiprofen enantiomers 
were studied in extraction system with aqueous phase containing 
0.3 mol:L-1 phosphate salt buffers with pH ranging from 2 to 8. 
Obviously, it can be seen from Figure 7 that the distribution 
coefficients of both enantiomers and enantioselectivity were 
strongly affected by the aqueous phase pH and decreased with 
the increase of pH sharply.  
Since the flurbiprofen is a weak acid drug with the pKa of 4.24, 
a large amount of flurbiprofen molecules changed into flurbiprofen 
ions as the pH increases, which caused the increase of the 
solubility of flurbiprofen in aqueous phase and the significant 
decrease of distribution coefficient. Meanwhile, the chiral ionic 
liquids have stronger interaction with the molecular flurbiprofen 
compared with flurbiprofen ions. The interactions between 
flurbiprofen enantiomer and the chiral selector decreased as pH 
increasing, resulting in a decrease of the separation factor. 
Therefore, the extraction process should be kept at lower pH. 
During this experiment, the optimal pH of the aqueous phase was 
fixed on 2.0. 
 
FIGURE 7 The influence of pH on distribution coefficients and enantioselectivity. The concentration of [Bmim][L-Trp] is 0.02 mol:L-1, the 
concentration of flurbiprofen is 0.2 mmol:L-1, 25 ഒ. 
 
3.5 Influence of [Bmim][L-Trp] concentration The effect of concentrations of chiral selector [Bmim][L-Trp] on 
distribution coefficients and enantioselectivity of flurbiprofen was 
investigated at pH 2.0, 25 ഒ and the result are shown in Figure 8. 
The distribution coefficients of both enantiomers obviously 
decreased with the increase of the concentration of [Bmim][L-Trp], 
because the higher concentration of [Bmim][L-Trp] leads to more 
guest-host compounds generated between [Bmim][L-Trp] and 
flurbiprofen molecules which cause higher concentration of 
flurbiprofen in aqueous phase. kS is greater than kR in the whole 
experimental concentration range, indicating that the interaction 
strength of R-flurbiprofen is always higher than that of S 
enantiomer. It can also be seen that enantioselectivity increased 
with the concentration of [Bmim][L-Trp] in low [Bmim][L-Trp] 
concentration range and reach the top at the concentration of 
[Bmim][L-Trp] 0.02 mol:L-1. With the further increase of [Bmim][L-
Trp] concentration, the enantioselectivity shows an opposite 
tendency, which can be explained by the enhanced non-selective 
recognition interactions between [Bmim][L-Trp] and flurbiprofen. 
Besides, it is noted that the concentration of chiral ionic liquids 
used is much less than that of the traditional extractants such as 
tartaric ester and く-cyclodextrin derivatives which could contribute 
to the cost reduction in the industrial application. 
 
FIGURE 8 The influence of concentration of [Bmim][L-Trp] on distribution coefficients and enantioselectivity. The concentration of flurbiprofen is 
0.2 mmol:L-1, pH = 2.0, 25 ഒ. 
 
3.6 Influence of flurbiprofen concentration 
The initial concentration of flurbiprofen racemates has effect on 
the concentration of complex formed by chiral selector and 
flurbiprofen, which can further affect the extraction process. 
Figure 9 shows the influence of initial flurbiprofen concentration 
on distribution coefficients and enantioselectivity at the 
concentration ranging from 0.08 to 0.4 mmol:L-1 (from 20 to 100 
たg:mL-1). Clear tendencies were observed from Figure 9 that the 
distribution coefficients increased with the initial concentration and 
the enantioselectivity followed the opposite.  
The similar phenomenon were observed by Tang when 
hydrophilic-cyclodextrin derivative was used as the aqueous 
phase extractants.34 That can be explained by that along with the 
increase of initial concentration, larger amounts of flurbiprofen 
molecules in aqueous phase are directly extracted into the organic 
phase without being selected, while the drugs molecules actually 
interacted with [Bmim][L-Trp] in the aqueous phase is limited, due 
to the lower solubility of flurbiprofen in aqueous phase. The 
gradually increase of the flurbiprofen molecules in organic phase 
causes the rise of distribution coefficients and the existence of 
more non-selective extraction leads to the decline of 
enantioselectivity. So the lower initial concentration is beneficial 
for higher enantioselectivity and 0.2 mmol:L-1 is selected as the 
suitable concentration in comprehensive consideration of 
extraction capacity. 
 
FIGURE 9 The influence of concentration of initial flurbiprofen racemates on distribution coefficients and enantioselectivity. The concentration of 
[Bmim][L-Trp] is 0.02 mol:L-1, pH = 2.0, 25 ഒ. 
 
3.7 Influence of temperature 
Temperature is an important factor in the liquid-liquid extraction 
process. In general, lower temperature is preferred to obtain 
better separation efficiency because both the selector-enantiomer 
interaction and discrimination ability of the selector for 
enantiomers usually weaken at a higher temperature.28,29,34,51 The 
conventional chiral drug extraction systems containing chiral 
selectors, like cyclodextrin derivative and tartaric acid derivative,  
exhibited a poor enantioselectivity, below 1.12, at room 
temperature (25 ˚C).  
In this work, the influence of temperature on extraction system 
was studied from 5 to 55 ഒ at 10 ഒ interval approximately and 
the results were shown in Figure 10. With the increase of 
temperature, the distribution coefficients of both enantiomers 
increase gradually and rise sharply when temperature is higher 
than 35 ഒ owing to the non-selective physical distributions. The 
enantioselectivity declines slightly with the increase of 
temperature from 0 to 25 ഒ and remains 1.21 at 25 ഒ because 
of the outstanding recognition ability of [Bmim][L-Trp]. When the 
temperature continues to increase above 35 ഒ, an increase of 
enantioselectivity has been observed due to the too large 
distribution coefficients and lower drug concentrations in aqueous 
phase which has an adverse impact on extraction process. 
Overall, the extraction performance near room temperature is 
improved by [Bmim][L-Trp] and decreases slightly compared with 
that at frigid temperature. Taking into account of the energy 
conservation and cost saving in practical industrial application, 25 ഒ 
is considered as a suitable extraction temperature. 
 
FIGURE 10 The influence of temperature on distribution coefficients and enantioselectivity. The concentration of [Bmim][L-Trp] is 0.02 mol:L-1, the 
concentration of flurbiprofen is 0.2 mmol:L-1, pH = 2.0. 
 
3.8 Recycling of [Bmim][L-trp] 
The reuse of ionic liquids is crucial for developing an economic 
and environmentally extraction separation process. In this work, a 
reverse extraction process was developed to recycle the 
[Bmim][L-trp] by collecting and reusing the whole aqueous phase 
after extraction without further separation and purification. 
Dichloromethane was chosen as the appropriate organic solvents 
in the reverse extraction process because of the higher 
distribution coefficients compared with dichloroethane and 
consequently higher reverse extraction rate. The results of HPLC 
analysis show that the concentration of flurbiprofen in the aqueous 
phase is below 0.3 たg:mL-1 after the reverse extraction and the 
reverse extraction rate is up to 98%. The performance of the 
reused [Bmim][L-trp] containing aqueous phase within 5 cycles is 
shown in Figure 11. Compared with the initial extraction process, 
the distribution coefficients obtained by the reverse extraction 
process remain stable and increase slightly after fifth reuse. 
Meanwhile, the enantioselectivity declines a little and remains 
above 1.20, indicating that the regenerated aqueous phase is 
saturated and stable, which has continuous and efficient 
separation ability. And there is almost no loss of [Bmim][L-trp]. 
 
FIGURE 11 The distribution coefficients and enantioselectivity of 
flurbiprofen in different recycles. The concentration of [Bmim][L-Trp] is 





In this work, a two phase liquid-liquid extraction system containing 
chiral ionic liquid in aqueous phase was proposed for the 
enantiosepration of flurbiprofen. The screening of the type of 
amino acid ionic liquids as extractant was performed by the 
assistance of quantum chemical calculation and was further 
verified through extraction experiments of different biphasic 
systems. [Bmim][L-Trp] was selected as the suitable chiral 
extractant. The influence of organic solvents, concentration of 
chiral extractants, initial concentration of flurbiprofen, pH values, 
and temperature on the extraction process were also investigated. 
Under the optimized condition, when dichloroethane is used as 
organic solvent, the concentration of [Bmim][L-Trp] is 0.02 mol:L-
1, the initial concentration of flurbiprofen is 0.2 mmol:L-1, the buffer 
pH is 2.0 and temperature is 25 ഒ, the distribution coefficients of 
R-flurbiprofen and S-flurbiprofen are 21.1 and 25.5, respectively. 
The enantioselectivity can reach to 1.24 at 5 ഒ and remain above 
1.20 near room temperature, exhibiting good separation effect on 
flurbiprofen enantiomers. Moreover, the recycle of aqueous phase 
was performed through a reverse extraction process to achieve 
the reuse of chiral ionic liquids. And the experiment data show that 
the regenerated aqueous phase still remains good separation 
ability. Thus, we successfully developed an enantioseparation 
system for flurbiprofen and the results can provide references for 
the further application of chiral ionic liquids in extraction. 
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